About Alphageneron Pharmaceuticals
Alphageneron Pharmaceuticals is a private company based in New York, New York, incorporated in 2020 in Delaware. It has reported $250,000 raised in one offering on Form D since August 2023. Its chief executive is Robert Brooks.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 20, 2023 | Aug 14, 2023 | $250,000fully sold | 1 | $250K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Alphageneron Pharmaceuticals's Form D filed Aug 14, 2023.
RB
Robert Brooks
Chief Executive Officer and director
OS
Ola Soderquist
Executive officer
ML
Marc Lippman
Director
BV
Bikash Verma
Director
RC
Robert Clarke
Director
GP
Graham Pockley
Executive officer